Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more
close menu × Sign Up Sign In

Spectrum visualisation currently is not available for this IC

Retinoic acid

Available only for Premium Members
1312 Number of Transfers Made
Add to Favorites
Add to IC Complex

All Trans Retinoic Acid (ATRA) is FDA approved in the treatment of promyelocytic leukemia. ATRA is a strong differentiating agent. As such, ATRA has potential as a therapy in a number of cancers, especially in the context of IC medicines. ATRA binds to retinoic acid receptors, and subsequently activates DNA transcription activity to move immature (e.g. malignant) cells toward normal maturation. Consider the use of ATRA in cases of cancer and precancerous lesions, including polyps, actinic keratosis, and others.

Primary Application: Imprint
For: People
IC Source: Allopathy
For: Mitochondrial and Energy Production System
For: Blood and Cardiovascular System
For: Immune System and Lymphatic System
For: Integumentary System

Some Complexes with this IC:

Available only for Premium Members
43 Number of Transfers Made
Add to Favorites
Show More
Copy Create a copy of this IC Complex and modify it as you wish
by Kraft&Gesundheit